HeartSciences (HSCS) vs SiNtx Technologies (SINT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HeartSciences (HSCS) has outperformed SiNtx Technologies (SINT) over the past year, losing 18.3% versus a loss of 53.3%. HeartSciences is the larger company by market cap ($14.7 million vs $14.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSCS | SINT |
|---|---|---|
| Share price | $3.04 | $2.11 |
| Market cap | $14.73M | $14.06M |
| 1-day change | -12.89% | -2.76% |
| YTD return | -1.62% | -45.34% |
| 1-year return | -18.28% | -53.32% |
| 5-year return | — | -99.99% |
| EPS (TTM) | $-3.21 | $-4.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.25 | $4.64 |
| 52-week low | $1.63 | $1.40 |
| Distance from 52-week high | -42.10% | -54.53% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +294.74% | +338.39% |
| Average volume | 154.08K | 112.93K |
| Shares outstanding | 4.84M | 6.66M |
| Employees | 14 | 32 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HSCS has outperformed SINT by 35.0 percentage points over the past year.
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Health Care · Industrial Specialties · 14 employees
About SiNtx Technologies
SINT stock →Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Health Care · Medical/Dental Instruments · 32 employees
HSCS vs SINT FAQ
Which is bigger, HeartSciences or SiNtx Technologies?
HeartSciences (HSCS) is larger, with a market capitalization of $14.73M compared with $14.06M for SiNtx Technologies (SINT).
Which stock has performed better over the past year, HSCS or SINT?
HSCS returned -18.28% over the past 12 months, compared with -53.32% for SINT (price return, excluding dividends). Past performance does not predict future results.
Are HeartSciences and SiNtx Technologies in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for HeartSciences and Medical/Dental Instruments for SiNtx Technologies.